Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Gaurav B Nigam"'
Autor:
Gaurav B. Nigam, Kelly Chatten, Ala Sharara, Talal Al-Taweel, Othman Alharbi, Hussein Elamin, Sameer Al Awadhi, Vito Annese, Jimmy K. Limdi
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Background: A growing body of evidence underscores the beneficial impact of therapeutic drug monitoring (TDM) on the efficacy and cost-effectiveness of anti-tumour necrosis factor (TNF) therapy in patients with inflammatory bowel disease (IBD). Objec
Externí odkaz:
https://doaj.org/article/d7e88d0c98624b65b341899585a0846e
Autor:
Gaurav B. Nigam, Jimmy K. Limdi
Publikováno v:
JGH Open, Vol 7, Iss 4, Pp 239-241 (2023)
Externí odkaz:
https://doaj.org/article/863b7c10441944fc9b54e0d7b1d33f94
Autor:
Anish J Kuriakose Kuzhiyanjal, Gaurav B Nigam, George A Antoniou, Francis A Farraye, Raymond K Cross, Jimmy K Limdi
Publikováno v:
Journal of Crohn's and Colitis.
Background and aims Technological advances have provided innovative, adaptive, and responsive models of care for inflammatory bowel diseases (IBD). We conducted a systematic review to compare e-health interventions with standard care in management of
Publikováno v:
Vasant, D H, Nigam, G B, Bate, S, Hamdy, S & Limdi, J K 2023, ' The prevalence and burden of Rome IV faecal incontinence in ulcerative colitis : A cross-sectional study ', Alimentary Pharmacology & Therapeutics . https://doi.org/10.1111/apt.17502
Background: Despite advances in ulcerative colitis (UC) therapies, a relatively undefined proportion of patients experience faecal incontinence (FI) in the absence of active inflammation. For this group, there remains a significant unmet need with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::887312a814d17609590e6b96792346bc
https://research.manchester.ac.uk/en/publications/a53dd6e9-1189-44ae-926d-5ff37f4a7be0
https://research.manchester.ac.uk/en/publications/a53dd6e9-1189-44ae-926d-5ff37f4a7be0
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 11 (2018)
Despite advances in inflammatory bowel disease (IBD) therapies, a significant proportion of patients with quiescent disease experience persistent, debilitating symptoms of faecal incontinence (FI), urgency and defaecatory disorders due to anorectal d
Externí odkaz:
https://doaj.org/article/8fbb959d4a524bd5b867d0814674a5fc
Publikováno v:
European Journal of Gastroenterology & Hepatology. 33:346-357
AIM The role of anti-tumour necrosis factor (TNF) medications in inflammatory bowel disease (IBD) is now established. Recent studies have reported the incidence of dermatological adverse events with use of anti-TNFs in IBD. The aim of this study was
Autor:
Gaurav B Nigam, Rajan N Patel, Sundeep Lakhtakia, Devendra Desai, Govind Makharia, Vineet Ahuja, Jimmy K Limdi
Publikováno v:
Inflammatory bowel diseases. 28(5)
Autor:
Michael F. Murphy, J Grant-Casey, D Clifton, Gaurav B. Nigam, Kathryn Oakland, A Thakur, Adrian J. Stanley, Vipul Jairath, Simon Travis, A Douds, P Dhiman
Publikováno v:
Posters – highly commended.
Autor:
Brian Bressler, Francis A. Farraye, Raj G. Jatale, Jimmy K. Limdi, Marietta Iacucci, Bu Hayee, Rajan N. Patel, Gaurav B. Nigam
Publikováno v:
Posters.
Autor:
Anish John Kuriakose Kuzhiyanjal, Francis A. Farraye, Gaurav B. Nigam, Raymond K. Cross, Georgios Antoniou, Jimmy K. Limdi
Publikováno v:
Abstracts of distinction.